The Association Between COVID-19 Vaccine/infection and New-onset Asthma in Children - Based on the Global TriNetX Database

Overview

Journal Infection

Date 2024 Jun 21

PMID 38904891

Authors

Chiao-Yu Yang

Yu-Hsiang Shih

Chia-Chi Lung

Affiliations

Soon will be listed here.

Abstract

Introduction: The COVID-19 pandemic has underscored the importance of its potential long-term health effects, including its link to new-onset asthma in children. Asthma significantly impacts children's health, causing adverse outcomes and increased absenteeism. Emerging evidence suggests a potential association between COVID-19 infection and higher rates of new-onset asthma in adults, raising concerns about its impact on children's respiratory health.

Methods: A retrospective cohort study design was employed, using electronic medical records from the TriNetX database, covering January 1, 2021, to December 31, 2022. Two cohorts of children aged 5 to 18 who underwent SARS-CoV-2 RT-PCR testing were analyzed: unvaccinated children with and without COVID-19 infection, and vaccinated children with and without infection. Propensity score matching was used to mitigate selection bias, and hazard ratio (HR) and 95% CI were calculated to assess the risk of new-onset asthma.

Results: Our study found a significantly higher incidence of new-onset asthma in COVID-19 infected children compared to uninfected children, regardless of vaccination status. In Cohort 1, 4.7% of COVID-19 infected children without vaccination developed new-onset asthma, versus 2.0% in their non-COVID-19 counterparts within a year (HR = 2.26; 95% CI = 2.158-2.367). For Cohort 2, COVID-19 infected children with vaccination showed an 8.3% incidence of new-onset asthma, higher than the 3.1% in those not infected (HR = 2.745; 95% CI = 2.521-2.99). Subgroup analyses further identified higher risks in males, children aged 5-12 years, and Black or African American children. Sensitivity analyses confirmed the reliability of these findings.

Conclusion: The study highlights a strong link between COVID-19 infection and an increased risk of new-onset asthma in children, which is even more marked in those vaccinated. This emphasizes the critical need for ongoing monitoring and customized healthcare strategies to mitigate the long-term respiratory impacts of COVID-19 in children, advocating for thorough strategies to manage and prevent asthma amidst the pandemic.

References

Harne R, Williams B, Abdelal H, Baldwin S, Coler R . SARS-CoV-2 infection and immune responses. AIMS Microbiol. 2023; 9(2):245-276. PMC: 10113164. DOI: 10.3934/microbiol.2023015. View

Patone M, Mei X, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M . Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex. Circulation. 2022; 146(10):743-754. PMC: 9439633. DOI: 10.1161/CIRCULATIONAHA.122.059970. View

Kang H . Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 2021; 18:17. PMC: 8441096. DOI: 10.3352/jeehp.2021.18.17. View

Echaide M, Chocarro de Erauso L, Bocanegra A, Blanco E, Kochan G, Escors D . mRNA Vaccines against SARS-CoV-2: Advantages and Caveats. Int J Mol Sci. 2023; 24(6). PMC: 10051235. DOI: 10.3390/ijms24065944. View

Floyd G, Dudley J, Xiao R, Feudtner C, Taquechel K, Miller K . Prevalence of asthma in hospitalized and non-hospitalized children with COVID-19. J Allergy Clin Immunol Pract. 2021; 9(5):2077-2079.e2. PMC: 7927636. DOI: 10.1016/j.jaip.2021.02.038. View

Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen T, Waris M, Korhonen K, Korppi M . Rhinovirus-induced wheezing in infancy--the first sign of childhood asthma?. J Allergy Clin Immunol. 2003; 111(1):66-71. PMC: 7112360. DOI: 10.1067/mai.2003.33. View

Vargas Centanaro G, Calle Rubio M, Alvarez-Sala Walther J, Martinez-Sagasti F, Hidalgo A, Herranz Hernandez R . Long-term Outcomes and Recovery of Patients who Survived COVID-19: LUNG INJURY COVID-19 Study. Open Forum Infect Dis. 2022; 9(4):ofac098. PMC: 8903519. DOI: 10.1093/ofid/ofac098. View

Rosas-Salazar C, Chirkova T, Gebretsadik T, Chappell J, Peebles Jr R, Dupont W . Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study. Lancet. 2023; 401(10389):1669-1680. PMC: 10367596. DOI: 10.1016/S0140-6736(23)00811-5. View

Liu L, Pan Y, Zhu Y, Song Y, Su X, Yang L . Association between rhinovirus wheezing illness and the development of childhood asthma: a meta-analysis. BMJ Open. 2017; 7(4):e013034. PMC: 5387933. DOI: 10.1136/bmjopen-2016-013034. View

10.

Szabo S, Levy A, Gooch K, Bradt P, Wijaya H, Mitchell I . Elevated risk of asthma after hospitalization for respiratory syncytial virus infection in infancy. Paediatr Respir Rev. 2012; 13 Suppl 2:S9-15. DOI: 10.1016/S1526-0542(12)70161-6. View

11.

Jartti T, Gern J . Role of viral infections in the development and exacerbation of asthma in children. J Allergy Clin Immunol. 2017; 140(4):895-906. PMC: 7172811. DOI: 10.1016/j.jaci.2017.08.003. View

12.

Jiang Y, Yan Q, Liu C, Peng C, Zheng W, Zhuang H . Insights into potential mechanisms of asthma patients with COVID-19: A study based on the gene expression profiling of bronchoalveolar lavage fluid. Comput Biol Med. 2022; 146:105601. PMC: 9117163. DOI: 10.1016/j.compbiomed.2022.105601. View

13.

Wimmers F, Burrell A, Feng Y, Zheng H, Arunachalam P, Hu M . Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth. Cell. 2023; 186(21):4632-4651.e23. PMC: 10724861. DOI: 10.1016/j.cell.2023.08.044. View

14.

Gao Y, Cai L, Li L, Zhang Y, Li J, Luo C . Emerging Effects of IL-33 on COVID-19. Int J Mol Sci. 2022; 23(21). PMC: 9658128. DOI: 10.3390/ijms232113656. View

15.

Ando M, Satonaga Y, Takaki R, Yabe M, Kan T, Omote E . Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty]). Int J Infect Dis. 2022; 124:187-189. PMC: 9477784. DOI: 10.1016/j.ijid.2022.09.019. View

16.

Gern J, Busse W . Association of rhinovirus infections with asthma. Clin Microbiol Rev. 1999; 12(1):9-18. PMC: 88904. DOI: 10.1128/CMR.12.1.9. View

17.

De Paula C, de Azevedo M, Nagashima S, Martins A, Malaquias M, Dos Santos Miggiolaro A . IL-4/IL-13 remodeling pathway of COVID-19 lung injury. Sci Rep. 2020; 10(1):18689. PMC: 7596721. DOI: 10.1038/s41598-020-75659-5. View

18.

Kim B, Lee H, Yeom S, Jeong C, Park D, Park T . Increased Risk of New-Onset Asthma After COVID-19: A Nationwide Population-Based Cohort Study. J Allergy Clin Immunol Pract. 2023; 12(1):120-132.e5. DOI: 10.1016/j.jaip.2023.09.015. View

19.

Jackson D, Makrinioti H, Rana B, Shamji B, Trujillo-Torralbo M, Footitt J . IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 2014; 190(12):1373-82. PMC: 4299647. DOI: 10.1164/rccm.201406-1039OC. View

20.

Sajuthi S, DeFord P, Li Y, Jackson N, Montgomery M, Everman J . Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium. Nat Commun. 2020; 11(1):5139. PMC: 7550582. DOI: 10.1038/s41467-020-18781-2. View